All Industries

Top Biotech Companies

3,138 Biotech companies, sorted by total funding raised.

Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series B·$612.0M·Oct 2022
Cellares

Cell therapy manufacturing company building automated factories to accelerate cell therapy produc...

South San Francisco, United States51–200Biotech, Healthcare
Series D·$612.0M·Jan 2026
N
NeumoraIPO

Clinical-stage biopharmaceutical company developing novel therapies for brain diseases.

South San Francisco, United States201–500Biotech
Series B·$612.0M·Oct 2022
Century TherapeuticsIPO

Century Therapeutics develops allogeneic iPSC-derived NK and T cell therapies for cancer and auto...

Philadelphia, United States51–200healthtech, Biotech
Corporate Round·$605.0M·Jan 2026
Ultima Genomics

Novel DNA sequencing architecture to scale the ultra low cost whole genome

Fremont, United States201–500Artificial Intelligence, Healthcare
Series A·$600.0M·May 2022
Edgewise TherapeuticsIPO

Clinical-stage biopharmaceutical company developing oral therapies for serious skeletal and cardi...

Boulder, United States51–200Biotech, Therapeutics
Growth Equity·$585.0M·Apr 2025
UPSIDE Foods

A pioneer in the cell-based meat industry.

Berkeley, United States201–500Biotech, Food Tech
Series C·$583.0M·Apr 2022
Colossal Biosciences

De-extinction and genetic engineering company working to bring back the woolly mammoth and other ...

Dallas, United States51–200Biotech, Genetics
Series D·$583.0M·Sep 2025
Science.xyz

Clinical-stage medical technology company developing neural-engineering implants and platforms to...

Alameda, United States51–200Biotech, Medtech
Series C·$583.0M·Mar 2026
Synthego

Provides CRISPR reagents, engineered nucleases, and GMP manufacturing to researchers and therapeu...

Redwood City, United States51–200Biotech, Genomics
Series E·$570.0M·Feb 2022
Cardurion

Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and ...

Burlington, United States11–50Biotech, Healthcare
Series B·$560.0M·Jul 2024
ElevateBio

ElevateBio is a biotech company powering transformative cell and gene therapies through integrate...

Cambridge, United States201–500Biotech
Venture Unknown·$551.0M·May 2023
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
Convertible·$550.1M·Aug 2025
Guardant HealthIPO

Guardant Health is an oncology company.

Palo Alto, United States1001–5000Biotech, Healthcare
Series E·$540.0M·May 2017
ON
Oxford NanoporeIPO

Developer of nanopore DNA and RNA sequencing technology enabling real-time portable genomic analy...

Oxford, United Kingdom1001–5000Biotech, Healthcare
Venture Unknown·$531.8M·Jan 2024
Beam TherapeuticsIPO

Biotechnology company developing precision genetic medicines through proprietary base editing tec...

Cambridge, United States201–500Biotech, Gene Editing
Growth Equity·$528.0M·Feb 2026
Relay TherapeuticsIPO

Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...

Cambridge, United States51–200Biotech, Drug Discovery
Series C·$520.0M·Dec 2018
Aviceda

World leader in glyco-immune checkpoint therapeutics developing immune-mediated therapies for pat...

United States51–200Biotech
Series C·$507.5M·Jan 2025
MetseraAcquired

Clinical-stage biopharmaceutical company developing next-generation oral and injectable medicines...

New York, United States11–50Biotech, Obesity
Series B·$505.0M·Nov 2024
RAPT TherapeuticsIPO

Clinical-stage biopharmaceutical developing immune-targeting therapeutics for inflammatory and im...

San Francisco, United States51–200Biotech, Healthcare
Private Equity·$497.0M·Oct 2025
GenentechIPO

Biotechnology company that discovers and develops medicines for serious, life-threatening disease...

San Francisco, United States10001+Biotech, Drug Discovery
Corporate Round·$492.3M·Feb 1990
ApellisIPO

Global biopharmaceutical company developing targeted C3 therapies to treat diseases driven by exc...

Waltham, United States501–1000Biotech
Corporate Round·$490.1M·Feb 2023
Kallyope

Kallyope leverages unique insights into neural signaling pathways to develop innovative medicines...

New York, United States51–200Biotech, Drug Discovery
Grant·$487.2M·May 2023
RecursionIPO

AI-powered drug discovery and development company that uses biological and chemical datasets, mac...

Salt Lake City, United States501–1000Artificial Intelligence, Biotech
Corporate Round·$482.9M·Jul 2023
Innovent BiologicsIPO

Developing and commercializing high-quality biologic medicines.

Suzhou, China5001–10000Biotech, Healthcare
Venture Unknown·$475.0M·Jan 2025